8-(1,3-benzoxazol-2-yl)-1-naphthoic acid
- $126 - $716.1
- Product name: 8-(1,3-benzoxazol-2-yl)-1-naphthoic acid
- CAS: 1142201-24-8
- MF: C18H11NO3
- MW: 289.28
- EINECS:
- MDL Number:MFCD12027981
- Synonyms:8-(1,3-benzoxazol-2-yl)-1-naphthoic acid;8-(Benzo[d]oxazol-2-yl)-1-naphthoic acid;1-Naphthalenecarboxylic acid, 8-(2-benzoxazolyl)-
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 500MG
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0131135
- Product description8-(1,3-BENZOXAZOL-2-YL)-1-NAPHTHOIC ACID 95.00%
- Packaging500MG
- Price$716.1
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM261808
- Product description8-(Benzo[d]oxazol-2-yl)-1-naphthoicacid 97%
- Packaging5g
- Price$376
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11347432
- Product description8-(Benzo[d]oxazol-2-yl)-1-naphthoicacid 97%
- Packaging5g
- Price$398
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number039504
- Product description8-(1,3-Benzoxazol-2-yl)-1-naphthoic acid
- Packaging500mg
- Price$126
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0131135 | 8-(1,3-BENZOXAZOL-2-YL)-1-NAPHTHOIC ACID 95.00% | 500MG | $716.1 | 2021-12-16 | Buy |
Chemenu | CM261808 | 8-(Benzo[d]oxazol-2-yl)-1-naphthoicacid 97% | 5g | $376 | 2021-12-16 | Buy |
Crysdot | CD11347432 | 8-(Benzo[d]oxazol-2-yl)-1-naphthoicacid 97% | 5g | $398 | 2021-12-16 | Buy |
Matrix Scientific | 039504 | 8-(1,3-Benzoxazol-2-yl)-1-naphthoic acid | 500mg | $126 | 2021-12-16 | Buy |
Properties
Boiling point :511.3±23.0 °C(Predicted)
Density :1.367±0.06 g/cm3(Predicted)
pka :2.61±0.10(Predicted)
Density :1.367±0.06 g/cm3(Predicted)
pka :2.61±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|